Difference between revisions of "Team:Tokyo Tech/Composite Part"

Line 107: Line 107:
 
<h2 align="center"><a href"http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</a> meets the Silver Medal criteria!</h2>
 
<h2 align="center"><a href"http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</a> meets the Silver Medal criteria!</h2>
 
 
<p class="normal_text">We simulated our final genetic circuits and found that the circuits did not work, because Prhl (<a href"http://parts.igem.org/Part:BBa_R0071">BBa_R0071</a>) strength was too weak. (see <a href="https://2016.igem.org/Team:Tokyo_Tech/Model"> the Model page </a> and <a href="https://2016.igem.org/Team:Tokyo_Tech/Model">the AHL Only Assay page). We therefore considered using the improved Prhl (<a href"http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a>, <a href"http://parts.igem.org/Part:BBa_K1529310">BBa_K1529310</a>) established by Tokyo_Tech 2014, but we noticed that they were inappropriate for two reasons (see our work <a href="https://2016.igem.org/Team:Tokyo_Tech/AHL_Assay/Rhl_System_Assay">Rhl_System_Assay</a>). Then, we decided to improve Prhl Promoter and obtain our original improved Prhl (included in <a href"http://parts.igem.org/BBa_K1949060">BBa_K1949060</a>) that suited our goal.
+
<p class="normal_text">We simulated our final genetic circuits and found that the circuits did not work, because Prhl (<a href"http://parts.igem.org/Part:BBa_R0071">BBa_R0071</a>) strength was too weak. (see <a href="https://2016.igem.org/Team:Tokyo_Tech/Model"> the Model page </a> and <a href="https://2016.igem.org/Team:Tokyo_Tech/Model">the AHL Only Assay page</a>). We therefore considered using the improved Prhl (<a href"http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a>, <a href"http://parts.igem.org/Part:BBa_K1529310">BBa_K1529310</a>) established by Tokyo_Tech 2014, but we noticed that they were inappropriate for two reasons (see our work <a href="https://2016.igem.org/Team:Tokyo_Tech/AHL_Assay/Rhl_System_Assay">Rhl_System_Assay</a>). Then, we decided to improve Prhl Promoter and obtain our original improved Prhl (included in <a href"http://parts.igem.org/BBa_K1949060">BBa_K1949060</a>) that suited our goal.
 
  Our purpose is to create strong Prhl for our final genetic circuits.
 
  Our purpose is to create strong Prhl for our final genetic circuits.
 
This experiment consists of the three parts below.</p>
 
This experiment consists of the three parts below.</p>

Revision as of 17:58, 18 October 2016

Prhl(NM)-rbs-gfp: BBa_K1949060

BBa_K1949060 meets the Silver Medal criteria!

We simulated our final genetic circuits and found that the circuits did not work, because Prhl (BBa_R0071) strength was too weak. (see the Model page and the AHL Only Assay page). We therefore considered using the improved Prhl (BBa_K1529300, BBa_K1529310) established by Tokyo_Tech 2014, but we noticed that they were inappropriate for two reasons (see our work Rhl_System_Assay). Then, we decided to improve Prhl Promoter and obtain our original improved Prhl (included in BBa_K1949060) that suited our goal. Our purpose is to create strong Prhl for our final genetic circuits. This experiment consists of the three parts below.

  1. Improved Prhl by iGEM 2014 Tokyo_Tech (BBa_K1529300, BBa_K1529310) and characterize RhlR assay (Fig.1 and Fig.2)

  2. Improvement of the wild type Prhl(BBa_R0071) (Fig.3)

  3. Comparison of the improved Prhl by iGEM 2014 Tokyo_Tech to our original improved Prhl (included in BBa_K1949060) (Fig.4)

The past improved Prhl did not suit for our final circuits and we could construct the improved Prhl appropriate to our final circuits.

Tokyo Tech 2015 iGEM Team: The Others Composite Parts

Name Type Description Design Length(bp)
BBa_K1949001 Measurement Pcold-gfp Yoshio Takata 1033
BBa_K1949032 Composite PBAD-rbs-yafO Yoshio Takata 1638
BBa_K1949033 Composite PBAD-rbs-yafO-tt-Ptet-rbs-gfp Yoshio Takata 2580
BBa_K1949052 Composite PBAD-rbs-amiE Yoshio Takata 2712
BBa_K1949060 Composite Prhl(NM)-rbs-gfp Yoshio Takata 799
BBa_K1949100 Composite Plac-rbs-mazE Yoshio Takata 565
BBa_K1949101 Composite PBAD-rbs-mazF Yoshio Takata 1575
BBa_K1949102 Composite PBAD-rbs-mazF-tt-Ptet-rbs-gfp Yoshio Takata 2520
BBa_K1949103 Composite Ptet-rbs(BBa_B0034))-mazE Yoshio Takata 332
BBa_K1949104 Composite Ptet-rbs(BBa_J61117)-mazE Yoshio Takata 332

yafON Composite Parts: BBa_K1949032 and BBa_K1949033

BBa_K1949032 meets the Silver Medal criteria!

YafN is an antitoxin corresponding to toxin YafO, and YafN reverses inhibition of cell growth. yafN and yafO exist as an operon, and YafN also functions as a repressor in the operon. Therefore, yafNO operon’s translation is autoregulated by antitoxin YafN. When Lon protease senses environmental stresses such as DNA damage, the operon becomes active because of degradation of YafN by Lon protease.

Confirming YafO Function as Toxin on Agar Medium

We first confirmed YafO function by observing formation of colony on agar medium. This experiment was carried out using E. coli which inducible YafO expression by arabinose and E. coli without yafO gene. Construction of plasmids used in this experiment is shown in bellow. We inoculated four types of E. coli differently on agar medium with and without arabinose. As a result, all types of E. coli were able to form colonies on agar medium with no arabinose, and colonies of E. coli (c) and (d) had fluorescence of GFP. On the other hand, E. coli (a) and (c) couldn’t form any colonies on agar medium containing arabinose. From these results, we confirmed that all types of E. coli in bellow functions as we expected.

Toxin-Antitoxin Assay

From previous experiment, we were able to confirm that YafO works as toxin. Next, we confirmed whether the cell growth reverses by antitoxin YafN after inhibition by YafO. Construction of plasmids used in this experiment is shown in bellow. We prepared E. coli which can induce expression of YafO by arabinose and YafN by lactose. As comparisons, we also carried out same experiment with E. coli containing no yafO gene, no yafN gene and none of them. As a result, we couldn’t observe cell growth reversing after adding IPTG to induce expression of YafN, and their turbidity became constant as E. coli (c) containing no yafN. In this experiment, YafN couldn’t reverse the cell growth after inhibition by YafO. It seems to be difficult to control cell growth just like mazEF system, which demonstrated reverse of cell growth by antitoxin after function of toxin.

mazFE Composite Parts: BBa_K1949100, BBa_K1949101, BBa_K1949102, (Best Composite Part!), BBa_K1949103 and BBa_K1949104

BBa_K1949100, BBa_K1949101 and BBa_K1949102 meets the Bronze Medal criteria!

Stop & Go

The biggest attraction of the TA system is that it is able to control cell growth and synthesis of protein. In this experiment, mazE expression was induced by the addition of IPTG(2 mM) after mazF expression was induced by the addition of arabinose(0.02%). As a result, it was able to resuscitate from a state of being inhibited cell growth. We named this experiment as "Stop & Go" because it was to resuscitate growth from inhibiting cell growth.

It was found from above picture that MazF inhibited cell growth. MazE was induced 2 h after MazE expression, and about 8 h later, cell growth was recovered that had stopped. From these results, it was suggested that E. coli whose cell growth was inhibited by MazF was able to resuscitate by expression of MazE. It was found from above picture that MazF inhibited cell growth. MazE was induced 2 h after MazE expression, and about 8 h later, cell growth was recovered that had stopped. From these results, it was suggested that E. coli whose cell growth was inhibited by MazF was able to resuscitate by expression of MazE.

Go & Stop

We found that a toxin inhibits cell growth, and an antitoxin resuscitates it. However, what will happen when a toxin is expressed after the antitoxin constitutive expression? Therefore, we conducted the experiment. Since cell growth was resuscitated after cells had grown, we named this experiment, "Go & Stop".

From above picture, E. coli encoded mazE which is on downstream of weak RBS(BBa_J61117) has more turbidity than E. coli encoded mazE which is on downstream of normal RBS(BBa_B0034). Both of those E. coli would reach Stationary phase when there is little RFU of GFP. E. coli encoded mazE which is on downstream of normal RBS reached almost the same stationary phase as E. coli without TA system.